RougeTx

Series-A
rougetx.com Biotech & Healthcare Naarden, The Netherlands
Total Funding $58M
Latest Round $58M Series-A
Last Announced Oct 6, 2026
Investors 10 Backers
Decision Makers Profile Active

About RougeTx

RougeTx is a biotech developing first-in-class small-molecule therapies for vascular diseases caused by pericyte dysfunction.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Naarden, The Netherlands
Tracked Since Oct 7, 2026

Web & Domain Identity

Official Website rougetx.com
Domain Registered Date May 22, 2024

Social & Network Presence

X / Twitter Profile @companies
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $58,000,000 · Series-A

    Backed by Angelini Ventures, BioGeneration Ventures

  2. Milestone

    Website domain registered

    rougetx.com

Investors & Backers

10
Angelini Ventures
Auréa
BioGeneration Ventures
Epidarex Capital
European Investment Bank Group
Kerna Ventures
Kurma Partners
p53
ROM Utrecht Region
Vesalius Biocapital Partners

Funding History

1 Round
Series-A equity · Oct 6, 2026

Round backers: Angelini Ventures, BioGeneration Ventures, Auréa, Epidarex Capital, European Investment Bank Group, Kerna Ventures, Kurma Partners, p53, ROM Utrecht Region, Vesalius Biocapital Partners

$58,000,000 finsmes.com

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts